Physician profile
Ellen D Drexler
NPI 1952301855
$5,914.89
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $5,157 · 2021: $70.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $5,015.64 | 2019-2020 | |
| Amgen INC. | $124.22 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $107.29 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $78.92 | 2019 | |
| Mdd US Operations, LLC | $69.16 | 2019-2021 | |
| Biogen, INC. | $66.11 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $60.27 | 2019 | |
| Supernus Pharmaceuticals, INC. | $55.79 | 2019 | |
| Grifols USA, LLC | $46.43 | 2019 | |
| Mallinckrodt Hospital Products INC. | $32.06 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $28.36 | 2019 | |
| Greenwich Biosciences, INC. | $27.37 | 2019 | |
| Merz North America, INC. | $27.03 | 2020 | |
| Medtronic USA, INC. | $24.79 | 2019 | |
| Genzyme Corporation | $24.50 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $23.52 | 2019 | |
| Acadia Pharmaceuticals INC | $19.54 | 2020 | |
| Emd Serono, INC. | $19.50 | 2019 | |
| Lundbeck LLC | $18.36 | 2019 | |
| Lilly USA, LLC | $16.67 | 2019 | |
| Csl Behring | $15.25 | 2019 | |
| Akcea Therapeutics, INC. | $14.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Drexler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.